The 2026 pain · diagnosed

The 3 B2B Pipeline Killers of 2026.

Why the playbook that worked in 2021 is now the playbook bleeding your pipeline.

Get your Pipeline Score → Get the SCAN diagnosis →
Sound familiar?
📊

You're spending on marketing. But you can't see what it's generating.
Events, LinkedIn, agency fees, campaigns — and at quarter-end you can't link any of it to closed deals. That's a visibility problem, not a budget one.

Your sales team is busy. But not closing fast enough.
Lots of activity, not enough wins. The marketing-to-sales handoff is broken — leads fall through, follow-up is inconsistent, deals die in no-decision.

🎯

You're losing deals to competitors who look more credible before the call.
Buyers shortlist vendors before they talk to sales. Unclear positioning means competitors win deals you never knew were on the table.

These aren't surface-level symptoms. There are three structural killers underneath — here's how to diagnose yours.

See the 3 Pipeline Killers ↓
Pipeline Killer #1

AI shortlists you before you know they exist.

48%
of B2B buyers use ChatGPT, Claude, or Perplexity to discover vendors
conversion rate of AI-referred visitors (14.2%) vs Google organic (2.8%)
94%
of CMOs report no meaningful AI integration in their GTM yet

Your buyer doesn't Google "B2B marketing consultant Belgium" anymore — they ask ChatGPT "Who are the top fractional CMOs for B2B SaaS in Europe?" If you're not in the answer, you're not on the shortlist, and you'll never know the RFP happened. GEO (Generative Engine Optimisation) is what SEO was in 2010 — most of your competitors aren't cited either, and that window closes fast.

RUTTENS+ builds your GEO foundation into every engagement — ICP-specific content that answers what your buyers ask AI right now, so you show up before you're searched for.

Get your Pipeline Score → Get the SCAN diagnosis →
Pipeline Killer #2

Half your deals don't lose to a competitor. They lose to inertia.

~50%
of stalled B2B deals die in "no decision" — not lost to a competitor
11
average stakeholders in a B2B buying committee
77%
of those stakeholders research independently before vendor contact

Your pipeline forecast shows €400K in late-stage deals. Quarter closes — and most of it didn't go to a competitor. The buyer just stopped: "revisit in Q3," "budget reallocated," "stakeholder changed." Every one is a no-decision loss.

Three things cause committee freeze: no proof the status quo costs more than change, no champion with enough authority, and perceived risk that outweighs perceived benefit. Fix one and the deal moves; leave all three and it dies quietly.

The fix: a business case the champion can take to their CFO, a fixed-scope entry that de-risks the spend, and a "cost of inaction" framing that makes the freeze more expensive than deciding. It's the move I run in every pipeline review — built into MAP and MAX from week one.

See the Pipeline Sprint →
Pipeline Killer #3

The cost to win each customer is up 60%. Your playbook is from 2021.

+60%
Rising cost to win each customer, over 5 years — across B2B sectors
81%
of B2B buyers decide vendors BEFORE engaging sales
#1
Brand awareness just beat lead generation as CMO priority — HubSpot 2026, first time ever

Volume is dead. Facebook ads, Google paid, cold email — CAC on all of them has climbed since 2021, and the curve isn't reversing. What compounds instead: a distinct POV buyers recognise before they meet you, and a pipeline built on warm intent rather than cold volume. Brand isn't soft — it's the CAC reducer.

RUTTENS+ builds a POV-first content engine: 2–3 posts per week that make your ICP think "they understand us" — content that earns AI citations rather than disappearing into the feed.

See all solutions →
Self-diagnosis · Free · 5 minutes

Not sure which one is killing yours?

Take the 5-minute GTM Animal Quiz. You'll get your archetype, the specific killer hitting your stage hardest, and 3 moves to fix it this quarter.

Take the GTM Animal Quiz →
Three ways in

How I fix this.

Start where it makes sense for your stage and budget. Every entry point leads to the same outcome: pipeline that works without you in every deal.

SCAN · Entry

1-hour working call with Phil + a written diagnosis delivered within a week. Your 3 biggest pipeline leaks named, with prioritised fixes and a recommended next step.

Who it's for: Leaders who need clarity before spending more.

Get the SCAN →
MAX · Fractional CMO

Fractional CMO embedded 10–20h/week. Strategy + execution. Full pipeline ownership from week one.

Who it's for: Scale-ups and PE/VC portfolios who need CMO-level leadership without a full-time hire.

More about MAX →
Compare all 5 solutions side by side →

Pipeline you can defend on Friday. 90 days.

Start with the free Pipeline Score — 2 minutes, no call, on-screen diagnosis.

Get your Pipeline Score → Email phil@ruttens.com
Get your Pipeline Score →